Global Raloxifene Hydrochloride Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 106017
- Pages: 108
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Raloxifene Hydrochloride market in this environment.
In terms of revenue, this research report indicated that the global Raloxifene Hydrochloride market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Raloxifene Hydrochloride industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Eli Lilly and Company aims at producing XX K Units Raloxifene Hydrochloride in 2020, with XX % production to take place in global market, InvaGen Pharmaceuticals Inc accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Raloxifene Hydrochloride Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Raloxifene Hydrochloride Market
Eli Lilly and Company
InvaGen Pharmaceuticals Inc
Actavis
Cadila Pharmaceuticals Ltd.
Zydus Alidac
Camber Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
Sanika Chemical Pvt Ltd.
Taj Pharmaceutical Limited
Jiangsu Hengrui Medicine Co. Ltd.
...
Major Type of Raloxifene Hydrochloride Covered in Prudent Markets report:
Tablet
Capsule
Application Segments Covered in Prudent Markets Market
Pharmaceuticals
Chemicals
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Raloxifene Hydrochloride Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Tablet -Product Introduction and Major Manufacturers
1.1.2 Capsule -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Raloxifene Hydrochloride Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Raloxifene Hydrochloride Market
3.1.1 Top Companies leading Raloxifene Hydrochloride Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Raloxifene Hydrochloride Market
3.2.1 Top Companies leading Raloxifene Hydrochloride Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Raloxifene Hydrochloride Market
3.3.1 Top Companies leading Raloxifene Hydrochloride Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Raloxifene Hydrochloride Market
3.4.1 Top Companies leading Raloxifene Hydrochloride Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Raloxifene Hydrochloride Market
3.5.1 Top Companies leading Raloxifene Hydrochloride Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Raloxifene Hydrochloride Market
3.6.1 Top Companies leading Raloxifene Hydrochloride Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Raloxifene Hydrochloride Market
3.7.1 Top Companies leading Raloxifene Hydrochloride Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Raloxifene Hydrochloride Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Raloxifene Hydrochloride Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Raloxifene Hydrochloride Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Raloxifene Hydrochloride Sales and Growth Rate (2021-2027)
5.2 Global Raloxifene Hydrochloride Sales Value and Growth Rate (2021-2027)
6 Raloxifene Hydrochloride Competitive Analysis
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Company Profiles
6.1.2 Eli Lilly and Company Product Introduction
6.1.3 Eli Lilly and Company Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 InvaGen Pharmaceuticals Inc
6.2.1 InvaGen Pharmaceuticals Inc Company Profiles
6.2.2 InvaGen Pharmaceuticals Inc Product Introduction
6.2.3 InvaGen Pharmaceuticals Inc Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Actavis
6.3.1 Actavis Company Profiles
6.3.2 Actavis Product Introduction
6.3.3 Actavis Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Cadila Pharmaceuticals Ltd.
6.4.1 Cadila Pharmaceuticals Ltd. Company Profiles
6.4.2 Cadila Pharmaceuticals Ltd. Product Introduction
6.4.3 Cadila Pharmaceuticals Ltd. Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Zydus Alidac
6.5.1 Zydus Alidac Company Profiles
6.5.2 Zydus Alidac Product Introduction
6.5.3 Zydus Alidac Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Camber Pharmaceuticals Inc.
6.6.1 Camber Pharmaceuticals Inc. Company Profiles
6.6.2 Camber Pharmaceuticals Inc. Product Introduction
6.6.3 Camber Pharmaceuticals Inc. Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Teva Pharmaceutical Industries Ltd.
6.7.1 Teva Pharmaceutical Industries Ltd. Company Profiles
6.7.2 Teva Pharmaceutical Industries Ltd. Product Introduction
6.7.3 Teva Pharmaceutical Industries Ltd. Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Sanika Chemical Pvt Ltd.
6.8.1 Sanika Chemical Pvt Ltd. Company Profiles
6.8.2 Sanika Chemical Pvt Ltd. Product Introduction
6.8.3 Sanika Chemical Pvt Ltd. Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Taj Pharmaceutical Limited
6.9.1 Taj Pharmaceutical Limited Company Profiles
6.9.2 Taj Pharmaceutical Limited Product Introduction
6.9.3 Taj Pharmaceutical Limited Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Jiangsu Hengrui Medicine Co. Ltd.
6.10.1 Jiangsu Hengrui Medicine Co. Ltd. Company Profiles
6.10.2 Jiangsu Hengrui Medicine Co. Ltd. Product Introduction
6.10.3 Jiangsu Hengrui Medicine Co. Ltd. Raloxifene Hydrochloride Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
